Vonovia Faces a Two-Pronged Berlin Test as Lawmakers Convene and Lenders Sound the Alarm

Vonovia is set to take its case against Berlin's expropriation plans into a Bavarian parliamentary hearing on October 27, a special session of the construction committee convened at the initiative of the CSU. The company, along with Heimstaden and Covivio, has confirmed it will attend, according to the CSU parliamentary group. For shareholders, the session is less about any binding decision—it cannot alter a Berlin law—than about how the landlord frames the scope of any transfers and the compensation that would accompany them.

The numbers involved explain why the debate matters. Vonovia owns 130,000 apartments in Berlin, with a market value of roughly EUR 23 billion, according to Tagesspiegel. The politically proposed compensation cap of EUR 16 billion, by contrast, applies to all affected companies combined. Those figures should not be read as a loss calculation for Vonovia: its total Berlin portfolio is not automatically identical to the number of units that would change hands, and no individual compensation has been fixed.

Under the outlines already under discussion, private landlords holding at least 10,000 Berlin apartments would be allowed to keep 10,000 units. Units built since 2021 or still under construction would also be excluded. That makes the new-build exemption a material piece of the puzzle for Vonovia, which has 1,000 apartments under construction in the city and has completed 1,600 there since 2021, according to the Tagesspiegel report. Which properties fall under the exceptions—and how any compensation is spread across the affected stock—will matter as much as the size of the portfolio itself.

A Long Road From Political Outline to Actual Transfer

Plenty of steps separate the current political framework from any real transfer of ownership. A draft law is planned for mid-2028, with entry into force envisaged a year after passage; constitutional review and litigation remain possible. Financing is another open question: the parties intend to fund compensation through loans and refinance them from rental income, so the plan's economic viability rests not only on the purchase-price substitute but also on financing costs and ongoing expenses.

Vonovia has not softened its opposition. The company told Welt on Monday that the planned expropriation, in the form presented, is unconstitutional and would not survive judicial review, adding that the outcome of the exploratory talks changes nothing about that stance. That legal argument, however, addresses a different question from the one raised this week by Germany's mortgage banks.

Lenders Flag Costlier Credit, Not Damage Already Done

The Association of German Pfandbrief Banks turned attention to the financing side of the debate. Its chief executive, Jens Tolckmitt, warned in comments to dpa that the project could make real estate loans more expensive and crowd out private lenders. The warning describes possible effects on real estate financing broadly; it is not a report of already higher borrowing costs at Vonovia, nor does it allow any concrete conclusion about the company's current financing terms. Higher credit costs and a retreat by private capital providers would be additional burdens should the fears materialize—a risk, not an incurred loss.

That distinction matters for how investors read the stock. Vonovia's argument rests on the legal viability of the plan; the association's warning concerns lending and the willingness of capital providers to commit. Neither statement substitutes for the other, and no court ruling accompanies either.

The next confirmed company date is the interim report for the third quarter of 2026, due on November 4, which will give investors a fresh basis for judging Vonovia's operating performance alongside the political risk. Until then, the separation holds: expropriation is a political project, unconstitutionality is Vonovia's position, and costlier real estate credit is a warning from the banking lobby. Keeping those threads apart is what prevents potential burdens from being treated as though they were already booked results.